As of Jan 22
| +1.65 / +9.30%|
The 5 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 20.00, with a high estimate of 30.00 and a low estimate of 6.00. The median estimate represents a +3.09% increase from the last price of 19.40.
The current consensus among 6 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.